The Life Insurance Market
A drug which is commonly used for diabetes sufferers might help people with critical illness cover stave off claiming on their policy by fighting cancer.
The National Cancer Institute (NCI) in the US has found that metformin could fight off colon cancer and even prevent smokers from developing lung cancer.
The researchers found that mice which were treated orally with metformin had between 40 and 50 fewer tumours, whilst those who had it injected had 72 per cent fewer.
Another study, published in the Cancer Prevention Research journal, found that the drug can fight colon cancer in a much more subtle way than chemo- and radiotherapy.
However, this doesn't spell the end to the need for critical illness cover, as metformin is a generic drug, meaning that companies have no financial incentive to fund research into its properties.
Post your own comment